AYTU BioPharma
AYTU
10 hedge funds and large institutions have $2.35M invested in AYTU BioPharma in 2018 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
233% more funds holding
Funds holding: 3 → 10 (+7)
159% more capital invested
Capital invested by funds: $907K → $2.35M (+$1.44M)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$1.95M |
| 2 |
HCM
Highbridge Capital Management
New York
|
+$1.84M |
| 3 |
CCM
Courage Capital Management
Nashville,
Tennessee
|
+$688K |
| 4 |
MA
MCF Advisors
Covington,
Kentucky
|
+$612K |
| 5 |
KJHP
K.J. Harrison & Partners
Toronto,
Ontario, Canada
|
+$351K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
Bard Associates
Chicago,
Illinois
|
-$71K |
| 2 |
HFM
Hartford Financial Management
Hartford,
Connecticut
|
-$15K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $956K | +$1.95M | +283 | +308% |
|
|
HCM
2
Highbridge Capital Management
New York
| $681K | +$1.84M | +267 | New |
|
|
CCM
3
Courage Capital Management
Nashville,
Tennessee
| $255K | +$688K | +100 | New |
|
|
MA
4
MCF Advisors
Covington,
Kentucky
| $227K | +$612K | +89 | New |
|
|
KJHP
5
K.J. Harrison & Partners
Toronto,
Ontario, Canada
| $129K | +$351K | +51 | New |
|
6
Citadel Advisors
Miami,
Florida
| $56K | +$151K | +22 | New |
|
|
NMC
7
NEA Management Company
Timonium,
Maryland
| $29K | +$75.7K | +11 | New |
|
8
Acadian Asset Management
Boston,
Massachusetts
| $7K | +$20.6K | +3 | New |
|
9
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $7K | +$20.6K | +3 | New |
|
10
UBS Group
Zurich,
Switzerland
| $2K | +$6.88K | +1 | New |
|
|
BA
11
Bard Associates
Chicago,
Illinois
| – | -$71K | -8 | Closed |
|
|
HFM
12
Hartford Financial Management
Hartford,
Connecticut
| – | -$15K | -2 | Closed |
|
AYTU Hedge Fund Activity: Q1 2018 in Review
10 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in AYTU BioPharma (AYTU) for Q1 2018, worth a combined $2.35M — up 159% from $907K a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new AYTU positions and 2 closed out — a net gain of 7 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Armistice Capital, adding an estimated $1.95M. The largest seller was Bard Associates, exiting entirely with an estimated $71K sold.
- 10 institutional investors held AYTU BioPharma (AYTU) as of Q1 2018, up from 3 in Q4 2017.
- Funds reported $2.35M of AYTU BioPharma stock for Q1 2018, up 159% quarter-over-quarter.
- 9 funds opened new AYTU BioPharma positions in Q1 2018 and 2 closed out, a net change of +7 holders.
- The largest AYTU BioPharma buyer in Q1 2018 was Armistice Capital, an estimated $1.95M added.
- The largest AYTU BioPharma seller in Q1 2018 was Bard Associates, an estimated $71K sold.
Based on aggregated 13F filings for Q1 2018.